Integrating PrEP into HIV care clinics could improve partner testing services and reinforce mutual support among couples: provider views from a PrEP implementation project in Kenya.


Journal

Journal of the International AIDS Society
ISSN: 1758-2652
Titre abrégé: J Int AIDS Soc
Pays: Switzerland
ID NLM: 101478566

Informations de publication

Date de publication:
07 2019
Historique:
received: 15 10 2018
accepted: 09 05 2019
entrez: 20 7 2019
pubmed: 20 7 2019
medline: 21 7 2020
Statut: ppublish

Résumé

Partner notification services (PNS) increase the HIV status knowledge and linkage to care and treatment. However, it is unclear if PNS can facilitate linkage of HIV-negative partners to prevention services such as pre-exposure prophylaxis (PrEP). Using qualitative methods, we explored provider perspective regarding the interaction of PrEP availability, PNS and antiretroviral treatment (ART) outcomes within a project integrating PrEP services into HIV care clinics in eight counties in western and central Kenya. From May 2017 to August 2018, data on integrated PrEP service delivery including its interaction with PNS were collected through 71 key informant in-depth interviews with healthcare providers and 24 standardized technical assistance reports summarizing implementation at the participating clinics. Thus, the perspective was from that of providers; analyses focused on emergent themes relating PNS to PrEP and ART services. Providers found that PrEP integration provided an additional concrete prevention option for HIV-negative partners and created a motivation to offer PNS to persons living with HIV. PrEP availability also seemed to operate as an incentive for those living with HIV to participate in PNS, which in turn enhanced identification of potential PrEP clients and created an environment for discussing HIV transmission risk. Providers commented that initiating HIV-negative partners on PrEP enhanced mutual monitoring of health outcomes, including improved adherence to ART by partners living with HIV. Clinics noted prioritizing people living with HIV with detectable viral loads for PNS in order to identify HIV-negative partners who would benefit most from PrEP. Providers felt motivated by the apparent synergistic interaction of PNS, PrEP and ART. Providers felt that the integration of PrEP into HIV care clinics stimulated the provision of PNS, and PNS was used to improve the identification of potential PrEP clients. The integrated combination of PNS, PrEP and ART is synergistic and should be promoted in HIV clinics.

Identifiants

pubmed: 31321911
doi: 10.1002/jia2.25303
pmc: PMC6639665
doi:

Substances chimiques

Anti-HIV Agents 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e25303

Subventions

Organisme : NIAID NIH HHS
ID : P30 AI027757
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH095507
Pays : United States
Organisme : Bill & Melinda Gates Foundation
ID : OPP1056051
Pays : United States
Organisme : NIH HHS
ID : R01 MH095507
Pays : United States

Informations de copyright

© 2019 The Authors. Journal of the International AIDS Society published by John Wiley & Sons Ltd on behalf of the International AIDS Society.

Références

JAMA. 2006 Aug 16;296(7):859-62
pubmed: 16905791
Gates Open Res. 2017 Nov 6;1:3
pubmed: 29355231
N Engl J Med. 2011 Aug 11;365(6):493-505
pubmed: 21767103
Nurs Stand. 2001 Jul 4-10;15(42):39-42
pubmed: 12212430
N Engl J Med. 2012 Aug 2;367(5):399-410
pubmed: 22784037
AIDS. 2017 Nov 13;31(17):2436-2437
pubmed: 29068836
J Int AIDS Soc. 2016 Dec 12;19(1):21134
pubmed: 27964776
J Int AIDS Soc. 2019 Jul;22 Suppl 3:e25303
pubmed: 31321911
J Int AIDS Soc. 2016 Nov 24;19(1):21224
pubmed: 27887669
Implement Sci. 2018 Sep 4;13(1):118
pubmed: 30180860
J Int AIDS Soc. 2017 Mar 8;20(Suppl 1):21331
pubmed: 28361502
PLoS Med. 2016 Aug 23;13(8):e1002099
pubmed: 27552090
AIDS Patient Care STDS. 2016 Nov;30(11):506-511
pubmed: 27849369
J Acquir Immune Defic Syndr. 2015 May 1;69 Suppl 1:S73-9
pubmed: 25867781
Cult Health Sex. 2018 Jun;20(6):625-639
pubmed: 28903628
Lancet HIV. 2017 Feb;4(2):e74-e82
pubmed: 27913227
BMC Public Health. 2018 Jul 4;18(1):825
pubmed: 29973167
J Acquir Immune Defic Syndr. 2014 Aug 1;66(4):436-42
pubmed: 24798765

Auteurs

Josephine B Odoyo (JB)

Kenya Medical Research Institute, Center for Microbiology Research, Nairobi, Kenya.

Jennifer F Morton (JF)

Department of Global Health, University of Washington, Seattle, WA, USA.

Kenneth Ngure (K)

Department of Global Health, University of Washington, Seattle, WA, USA.
Department of Community Health, Jomo Kenyatta University of Agriculture and Technology, Nairobi, Kenya.

Gabrielle O'Malley (G)

Department of Global Health, University of Washington, Seattle, WA, USA.

Kenneth K Mugwanya (KK)

Department of Global Health, University of Washington, Seattle, WA, USA.

Elizabeth Irungu (E)

Department of Global Health, University of Washington, Seattle, WA, USA.
Kenya Medical Research Institute, Center for Clinical Research, Nairobi, Kenya.

Merceline Awuor (M)

Kenya Medical Research Institute, Center for Microbiology Research, Nairobi, Kenya.

Annabell Dolla (A)

Kenya Medical Research Institute, Center for Microbiology Research, Nairobi, Kenya.

Fernandos Ongolly (F)

Kenya Medical Research Institute, Center for Clinical Research, Nairobi, Kenya.

Elizabeth A Bukusi (EA)

Kenya Medical Research Institute, Center for Microbiology Research, Nairobi, Kenya.
Department of Global Health, University of Washington, Seattle, WA, USA.
Department of Obstetrics and Gynecology, University of Washington, Seattle, WA, USA.

Nelly R Mugo (NR)

Department of Global Health, University of Washington, Seattle, WA, USA.
Kenya Medical Research Institute, Center for Clinical Research, Nairobi, Kenya.

Jared M Baeten (JM)

Department of Global Health, University of Washington, Seattle, WA, USA.
Department of Medicine, University of Washington, Seattle, WA, USA.
Department of Epidemiology, University of Washington, Seattle, WA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH